LEAH FLANIGAN: Open Payments
NPI 1669993614 · WATERFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 13 payments from 11 companies in 2025. Trend: 2023 $653 · 2024 $883 · 2025 $1,489
Food & beverage: $1,489
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 2 | $249 |
| Averitas Pharma Inc. | 1 | $145 |
| Axsome Therapeutics, Inc. | 2 | $135 |
| Novo Nordisk Inc | 1 | $125 |
| JAZZ PHARMACEUTICALS INC. | 1 | $125 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $125 |
| Indivior Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Madrigal Pharmaceuticals | 1 | $107 |
Products named: BRIXADI, QUTENZA, Auvelity, Wegovy, EPIDIOLEX, JOURNAVX, SUBLOCADE, REXULTI.
Industry payments across MI — which companies pay providers there.
